Literature DB >> 1664039

Effects of chronic manganese treatment on rat brain regional sodium-potassium-activated and magnesium-activated adenosine triphosphatase activities during development.

J C Lai1, T K Leung, L Lim, A W Chan, M J Minski.   

Abstract

The effects of chronic manganese (Mn) treatments (1 and 10 mg MnCl2.4H2O per ml of drinking water) from conception onwards on brain regional development of sodium-potassium-activated and magnesium-activated adenosine triphosphatases (Na-K-ATPase and Mg-ATPase) were studied. The activities of these enzymes were determined in hypothalamus, cerebellum, pons and medulla, striatum, midbrain and cerebral cortex (which included the hippocampus) of Mn-treated and age-matched control rats at 5 postnatal ages. Both ATPase activities doubled in most brain regions between day 5 and day 20 postnatal. In pons and medulla, striatum, midbrain, and cerebral cortex, adult levels of both enzymatic activities were attained by day 20 postnatal. Na-K-ATPase activities transiently increased in the midbrain (+25%) at day 12 with the lower Mn dose and in the cerebral cortex (+31%) at day 20 with the higher Mn dose. With the higher Mn dose only, Mg-ATPase activities were increased in the hypothalamus (+20%) at day 12 and in the pons and medulla (+22%) at day 20 but were decreased in the pons and medulla (-20%) at day 60. Thus, only transient changes in enzymatic activities were observed despite dose-dependent increases in the brain levels of Mn resulting from the Mn treatment. A hypothesis regarding the role of early but transient changes in brain metabolism in the pathogenesis of the initial psychotic symptoms in Mn intoxication was proposed and discussed in relation to several other observations of a similar nature.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1664039     DOI: 10.1007/bf00996908

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  30 in total

1.  The modifying effect of manganese on the enzymic profiles and pathways of carbohydrate metabolism in rat liver and adipose tissue during development.

Authors:  N Z Baquer; J S Hothersall; A L Greenbaum; P McLean
Journal:  Biochem Biophys Res Commun       Date:  1975-02-03       Impact factor: 3.575

2.  Brain Na+,K+-ATPase activity possibly regulated by a specific serotonin receptor.

Authors:  J Hernández
Journal:  Brain Res       Date:  1987-04-07       Impact factor: 3.252

3.  Brain serotonin synthesis and Na+,K+-ATPase activity are increased postnatally after prenatal administration of L-tryptophan.

Authors:  J Hernández-Rodríguez; G Chagoya
Journal:  Brain Res       Date:  1986-03       Impact factor: 3.252

Review 4.  Undernutrition and the development of brain neurotransmitter systems.

Authors:  R C Wiggins; G Fuller; S J Enna
Journal:  Life Sci       Date:  1984-11-19       Impact factor: 5.037

5.  (Na+-K+)-ATPase activity and ouabain-binding sites in the cerebral cortex of young and aged Fischer-344 rats.

Authors:  J C LaManna; G Doull; K McCracken; S I Harik
Journal:  Gerontology       Date:  1983       Impact factor: 5.140

6.  The effects of cadmium, manganese and aluminium on sodium-potassium-activated and magnesium-activated adenosine triphosphatase activity and choline uptake in rat brain synaptosomes.

Authors:  J C Lai; J F Guest; T K Leung; L Lim; A N Davison
Journal:  Biochem Pharmacol       Date:  1980-02       Impact factor: 5.858

7.  The effects of transition-metal ions on rat brain synaptosomal amine-uptake systems.

Authors:  J C Lai; J F Guest; L Lim; A N Davison
Journal:  Biochem Soc Trans       Date:  1978       Impact factor: 5.407

8.  Changes in brain regional manganese and magnesium levels during postnatal development: modulations by chronic manganese administration.

Authors:  A W Chan; M J Minski; L Lim; J C Lai
Journal:  Metab Brain Dis       Date:  1992-03       Impact factor: 3.584

9.  The regional distribution of monoamine oxidase activities towards different substrates: effects in rat brain of chronic administration of manganese chloride and of ageing.

Authors:  T K Leung; J C Lai; L Lim
Journal:  J Neurochem       Date:  1981-06       Impact factor: 5.372

10.  Differences in the inhibitory effect of Cd2+, Mn2+ and Al3+ on the uptake of dopamine by synaptosomes from forebrain and from striatum of the rat.

Authors:  J C Lai; L Lim; A N Davison
Journal:  Biochem Pharmacol       Date:  1981-11-15       Impact factor: 5.858

View more
  5 in total

1.  Ontogenetic exposure of rats to pre- and post-natal manganese enhances behavioral impairments produced by perinatal 6-hydroxydopamine.

Authors:  Przemysław Nowak; Kamila Bojanek; Ryszard Szkilnik; Jadwiga Jośko; Dariusz Boroń; Marta Adwent; Piotr Gorczyca; Richard M Kostrzewa; Ryszard Brus
Journal:  Neurotox Res       Date:  2010-04-06       Impact factor: 3.911

2.  Effect of pre- and postnatal manganese exposure on brain histamine content in a rodent model of Parkinson's disease.

Authors:  Ryszard Brus; Jerzy Jochem; Przemysław Nowak; Marta Adwent; Dariusz Boroń; Halina Brus; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2011-08-06       Impact factor: 3.911

3.  Changes in brain regional manganese and magnesium levels during postnatal development: modulations by chronic manganese administration.

Authors:  A W Chan; M J Minski; L Lim; J C Lai
Journal:  Metab Brain Dis       Date:  1992-03       Impact factor: 3.584

4.  Brain regional distributions of monoamine oxidase activities in postnatal development in normal and chronically manganese-treated rats.

Authors:  T K Leung; L Lim; J C Lai
Journal:  Metab Brain Dis       Date:  1993-09       Impact factor: 3.584

5.  Astrocyte-specific deletion of the transcription factor Yin Yang 1 in murine substantia nigra mitigates manganese-induced dopaminergic neurotoxicity.

Authors:  Edward Pajarillo; James Johnson; Asha Rizor; Ivan Nyarko-Danquah; Getinet Adinew; Julia Bornhorst; Michael Stiboller; Tania Schwerdtle; Deok-Soo Son; Michael Aschner; Eunsook Lee
Journal:  J Biol Chem       Date:  2020-09-06       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.